Additional Details
-
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Washington University (Site #: 71157)St Louis MO. 63130View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
NYU Langone Health (Site #: 71177)New York NY. 10016View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
University of Pennsylvania (Site #: 71111)Philadelphia PA. 19104View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Cincinnati Children's Hospital Medical Center (Site #: 71017)Cincinnati OH. 45229View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
University of California, Los Angeles (Site #: 71123)Los Angeles CA. 90095View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Cleveland Clinic (Site #: 71101)Cleveland OH. 44195View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Johns Hopkins (Site #: 71119)Baltimore MD. 21287View Details -
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
Duke University (Site #: 71139)Durham NC. 27710View Details -
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
The University of Texas Health Science Center at HoustonHouston TX. 77030View Details -
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
MD Anderson Cancer CenterHouston TX. 77030View Details -
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
University of California San FranciscoSan Francisco CA. 94143View Details -
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
University of MichiganAnn Arbor MI. 48109View Details -
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
University of KansasKansas City KS. 66103View Details -
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
University of Colorado DenverAurora CO. 80045View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University of Rochester MedicineRochester NY. 14623View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Sentara Norfolk General HospitalNorfolk VA. 23507View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Cedars-Sinai Medical CenterLos Angeles CA. 90048View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
University Hospitals Cleveland Medical CenterCleveland OH. 44106View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
HMH Jersey Shore University Medical Ctr.Neptune City NJ. 07753View Details -
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Dartmouth Hitchcock Medical CenterLebanon NH. 03766View Details